Core Insights - Progyny, Inc. has announced a collaboration with Amazon's Health Benefits Connector to enhance access to comprehensive women's health services [1][3] - The partnership aims to simplify the process for eligible individuals to discover and enroll in Progyny benefits through their employers or health plans [1][3] Company Overview - Progyny is a global leader in women's health and family building solutions, serving over 530 employers and health plans in the U.S. and supporting more than 6.7 million lives [2][5] - The company's benefits cover the entire reproductive health continuum, including fertility, preconception, pregnancy, postpartum, menopause, and parenting support, while achieving superior outcomes and member satisfaction [2][5] Collaboration Details - The collaboration with Amazon is significant as Progyny becomes the first comprehensive women's health provider on Amazon's Health Benefits Connector, facilitating easier access to its services [3][4] - Amazon's Health Benefits Connector addresses the challenge of individuals not understanding their available health benefits, allowing customers to verify access to Progyny with just a few clicks [3][4] Strategic Vision - Both companies aim to create market-leading solutions that simplify access to high-quality, inclusive care, making it the industry standard [4] - Progyny's approach includes concierge support, coaching, education, and digital tools, along with access to a premier network of specialists, driving optimal clinical outcomes and reducing healthcare costs [6][5] Recognition and Growth - Progyny has received multiple accolades for its leadership and growth, including being named a TIME100 Most Influential Company and a CNBC Disruptor 50 [7]

Company Overview - Progyny, Inc. is a global leader in women's health and family building solutions, trusted by leading employers, health plans, and benefit purchasers [3][5] - The company aims to create a world where everyone can achieve their family and health aspirations through comprehensive and inclusive solutions [3] Recent Events - Progyny's CEO Pete Anevski and CFO Mark Livingston will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time [1] Services and Solutions - Progyny offers a benefits solution that includes concierge support, coaching, education, and digital tools, providing access to a premier network of fertility and women's health specialists [4] - The company's approach is designed to drive optimal clinical outcomes while reducing healthcare costs [4] Recognition and Awards - Progyny has received multiple accolades, including being named a TIME100 Most Influential Company, CNBC Disruptor 50, and recognized by Modern Healthcare, Forbes, Financial Times, and Inc. for its leadership and growth [5]

Core Insights - Progyny, Inc. reported record revenue of $324.0 million for Q1 2025, reflecting a 16.5% growth compared to $278.1 million in Q1 2024, driven by an increase in clients and covered lives [4][5][14] - The company raised its full-year guidance due to a strong start to the year and ongoing demand in women's health and family building solutions [1][16] - Member engagement remains consistent with historical levels, indicating a strong desire for family building among members [3][12] Financial Performance - Revenue for Q1 2025 was $324.0 million, a 16.5% increase from $278.1 million in Q1 2024 [4][5] - Gross profit increased by 21% to $75.8 million, with a gross margin of 23.4%, up from 22.4% in the prior year [7][14] - Net income was $15.1 million, or $0.17 per diluted share, compared to $16.9 million, also $0.17 per diluted share, in Q1 2024 [8][34] - Adjusted EBITDA rose 15% to $57.8 million, with an adjusted EBITDA margin of 17.8%, slightly down from 18.1% in Q1 2024 [9][14] Cash Flow and Financial Position - Net cash provided by operating activities was $49.8 million in Q1 2025, compared to $25.7 million in Q1 2024, attributed to higher profitability [10] - As of March 31, 2025, the company had total working capital of approximately $330.6 million and no debt, with cash and cash equivalents totaling $256.1 million [11] Client Metrics - The company had 532 fertility and family building clients as of March 31, 2025, up from 451 clients a year earlier [12] - Fertility benefit services revenue was $206.4 million, a 22% increase from $169.8 million in Q1 2024, while pharmacy benefit services revenue increased by 9% to $117.6 million [14] Guidance and Outlook - For the full year 2025, revenue is projected to be between $1.185 billion and $1.235 billion, reflecting growth of 1.5% to 5.8% [20] - The second quarter of 2025 is expected to generate revenue between $310.0 million and $325.0 million, with net income projected between $11.5 million and $14.5 million [20]

Group 1 - Progyny, Inc. will report its financial results for the quarterly period ended March 31, 2025, on May 8, 2025, after market close [1] - A conference call will be held at 4:45 p.m. Eastern Time on the same day, with a press release issued prior to the call [1] - Interested participants can access the conference call via specific phone numbers and passcodes provided for both U.S. and international participants [2] Group 2 - An audio replay of the conference call will be available until May 15, 2025, with access details also provided [2] - A live webcast and archive of the call will be accessible from the Events and Presentations section of Progyny's website [3] Group 3 - Progyny is recognized as a global leader in women's health and family building solutions, serving leading employers and health plans [4] - The company aims to provide comprehensive and inclusive solutions that benefit employers, patients, and physicians [4] - Progyny's benefits solution includes concierge support, coaching, education, and access to a network of fertility and women's health specialists [5] Group 4 - Progyny is headquartered in New York City and has received multiple accolades for its leadership and growth, including recognition from TIME, CNBC, and Forbes [6]